Asia-pacific Contrast Enhanced Ultrasound Market Forecast 2022-2030

Asia-pacific Contrast Enhanced Ultrasound Market Forecast 2022-2030

KEY FINDINGS

The Asia-Pacific contrast enhanced ultrasound market is set to rise with a CAGR of 5.54% over the forecasting years of 2022 to 2030. The market growth of the region is facilitated by the lack of well-organized reimbursement policies boosting the demand for affordable procedures as well as the rapid improvement in healthcare expenditure, primarily in developing countries such as China and India.

MARKET INSIGHTS

The Asia-Pacific contrast enhanced ultrasound market growth evaluation covers the assessment of Taiwan, Australia & New Zealand, India, South Korea, Indonesia, China, Japan, Singapore, and Rest of Asia Pacific. Contrast ultrasound manufacturers are collaborating with domestic medical technology businesses in India for the purpose of marketing, distribution, and production of contrast agents. This cooperation helps overseas businesses in proliferating their sales and distribution networks as well. For example, SonoVue (Sulphur Hexafluoride UCA) was distributed in India owing to the partnership between Bracco Diagnostic Inc and Trivitron Healthcare, one of the industry leaders in the ultrasound sector in India.

On the other hand, India also has a poor health care system, which fuels the demand for cost-effective imaging techniques such as contrast enhanced ultrasonography. Presently, ultrasound services for legal health screenings are prevalent across the country, with more people expected to use ultrasound tests exclusively for medical purposes. Therefore, these factors are set to play an essential role in propelling the contrast enhanced ultrasound market growth in the Asia-Pacific over the forecast period.

COMPETITIVE INSIGHTS

Key players operating in the market are Koninklijke Philips NV, Trivitron Healthcare Pvt Ltd, etc.

Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation caters to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• The competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments


1. Research Scope & Methodology
1.1. Study Objectives
1.2. Scope Of Study
1.3. Methodology
1.4. Assumptions & Limitations
2. Executive Summary
2.1. Market Size & Estimates
2.2. Market Overview
3. Market Dynamics
3.1. Key Drivers
3.1.1. Surging Prevalence Of Chronic Diseases
3.1.2. Health Practitioners Prefer Contrast Enhanced Ultrasound Imaging
3.1.3. Technological Advancements In Diagnosis
3.2. Key Restraints
3.2.1. Non-uniformity Of Contrast Agents
3.2.2. Difficulty In Adoption In The Current Healthcare System
4. Key Analytics
4.1. Impact Of Covid-19 On Contrast Enhanced Ultrasound Market
4.2. Key Market Trends
4.3. Porter’s Five Forces Analysis
4.3.1. Buyers Power
4.3.2. Suppliers Power
4.3.3. Substitution
4.3.4. New Entrants
4.3.5. Industry Rivalry
4.4. Opportunity Matrix
4.5. Vendor Landscape
4.6. Value Chain Analysis
4.7. Key Buying Criteria
4.7.1. Cost Efficiency
4.7.2. Product Features
4.7.3. End-use
4.8. Regulatory Framework
5. Market By Product
5.1. Equipment
5.2. Contrast Agent
6. Market By Type
6.1. Non-targeted
6.2. Targeted
7. Market By End-user
7.1. Hospitals
7.2. Clinics
7.3. Ambulatory Diagnostic Centers
8. Geographical Analysis
8.1. Asia-pacific
8.1.1. Market Estimates & Sizes
8.1.2. Key Growth Enablers
8.1.3. Key Challenges
8.1.4. Key Players
8.1.5. Country Analysis
8.1.5.1. China
8.1.5.2. Japan
8.1.5.3. India
8.1.5.4. South Korea
8.1.5.5. Indonesia
8.1.5.6. Singapore
8.1.5.7. Taiwan
8.1.5.8. Australia & New Zealand
8.1.5.9. Rest Of Asia-pacific
9. Competitive Landscape
9.1. Key Strategic Developments
9.1.1. Mergers & Acquisitions
9.1.2. Product Launches & Developments
9.1.3. Partnerships & Agreements
9.1.4. Business Expansions & Divestitures
9.2. Company Profiles
9.2.1. Bayer Ag
9.2.2. Bracco Diagnostic Inc
9.2.3. Daiichi Sankyo Company Limited
9.2.4. Ge Healthcare
9.2.5. Koninklijke Philips Nv
9.2.6. Lantheus Medical Imaging Inc
9.2.7. Nanopet Pharma Gmbh
9.2.8. Sanochemia Pharmazeutika Gmbh
9.2.9. Shenzhen Mindray Bio-medical Electronics Co Ltd
9.2.10. Siemens Healthineers Ag
9.2.11. Taejoon Pharm
9.2.12. Trivitron Healthcare

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings